The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues
- PMID: 16299104
- PMCID: PMC1297670
- DOI: 10.1073/pnas.0506844102
The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues
Abstract
Various attempts to detect human pituitary growth hormone-releasing hormone receptor (pGHRH-R) in neoplastic extrapituitary tissues have thus far failed. Recently, four splice variants (SVs) of GHRH-R have been described, of which SV1 has the highest structural homology to pGHRH-R and likely plays a role in tumor growth. The aim of this study was to reinvestigate whether human tumors and normal human extrapituitary tissues express the pGHRH-R and to corroborate our previous findings on its SVs. Thus, we developed a real-time PCR method for the detection of the mRNA for the pGHRH-R, its SVs, and the GHRH peptide. Using real-time PCR, Western blotting, and radioligand-binding assays, we detected the mRNA for pGHRH-R and pGHRH-R protein in various human cancer cell lines grown in nude mice and in surgical specimens of human lung cancers. The expression of mRNA for SVs of pGHRH-R and GHRH was likewise found in xenografts of human non-Hodgkin's lymphomas, pancreatic cancer, glioblastoma, small-cell lung carcinomas, and in human nonmalignant prostate, liver, lung, kidney, and pituitary. Western blots showed that these normal and malignant human tissues contain SV1 protein and immunoreactive GHRH. Our results demonstrate that some normal human tissues and tumors express mRNA and protein for the pGHRH-R and its splice variants. These findings confirm and extend the concept that GHRH and its receptors play an important role in the pathophysiology of human cancers.
Figures
Similar articles
-
Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.J Clin Endocrinol Metab. 2002 Oct;87(10):4707-14. doi: 10.1210/jc.2002-020347. J Clin Endocrinol Metab. 2002. PMID: 12364462
-
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours.Clin Endocrinol (Oxf). 2005 May;62(5):533-8. doi: 10.1111/j.1365-2265.2005.02253.x. Clin Endocrinol (Oxf). 2005. PMID: 15853821
-
Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in Primary Human Endometrial Carcinomas: Novel Therapeutic Approaches.Molecules. 2022 Apr 21;27(9):2671. doi: 10.3390/molecules27092671. Molecules. 2022. PMID: 35566020 Free PMC article.
-
Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer.Nat Clin Pract Endocrinol Metab. 2008 Jan;4(1):33-43. doi: 10.1038/ncpendmet0677. Nat Clin Pract Endocrinol Metab. 2008. PMID: 18084344 Review.
-
Growth hormone releasing hormone receptor.Recept Channels. 2002;8(3-4):155-62. Recept Channels. 2002. PMID: 12529933 Review.
Cited by
-
New therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormones.Asian J Androl. 2015 Nov-Dec;17(6):925-8. doi: 10.4103/1008-682X.152819. Asian J Androl. 2015. PMID: 26112478 Free PMC article.
-
Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1655-60. doi: 10.1073/pnas.1120588109. Epub 2012 Jan 18. Proc Natl Acad Sci U S A. 2012. PMID: 22307626 Free PMC article.
-
Growth hormone-releasing hormone receptor splice variant 1 is frequently expressed in oral squamous cell carcinomas.Horm Cancer. 2012 Aug;3(4):172-80. doi: 10.1007/s12672-012-0108-8. Epub 2012 Mar 23. Horm Cancer. 2012. PMID: 22441816 Free PMC article.
-
Growth Hormone-Releasing Hormone in Endothelial Inflammation.Endocrinology. 2022 Dec 19;164(2):bqac209. doi: 10.1210/endocr/bqac209. Endocrinology. 2022. PMID: 36503995 Free PMC article. Review.
-
Podocytopathy in diabetes: a metabolic and endocrine disorder.Am J Kidney Dis. 2011 Oct;58(4):637-46. doi: 10.1053/j.ajkd.2011.03.035. Epub 2011 Jun 29. Am J Kidney Dis. 2011. PMID: 21719174 Free PMC article. Review.
References
-
- Schally, A. V. (2003) in Peptides and Nonpeptides of Neuroendocrine and Oncological Relevance, ed. Muller, E. E. (Springer, Milan), pp. 83-98.
-
- Schally, A. V. & Varga, J. L. (1999) Trends Endocrinol. Metab. 10, 383-391. - PubMed
-
- Schally, A. V., Comaru-Schally, A. M., Nagy, A., Kovacs, M., Szepeshazi, K., Plonowski, A., Varga, J. L. & Halmos, G. (2001) Front. Neuroendocrinol. 22, 248-291. - PubMed
-
- Szepeshazi, K., Schally, A. V., Groot, K., Armatis, P., Hebert, F. & Halmos, G. (2000) Eur. J. Cancer 36, 128-136. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources